Chronic intestinal pseudo-obstruction.
暂无分享,去创建一个
Francesca Pallotti | G. Barbara | R. De Giorgio | R. Corinaldesi | F. Pallotti | V. Stanghellini | R. Cogliandro | L. Cogliandro | Roberto Corinaldesi | Alexandra Antonucci | Lucia Fronzoni | Laura Cogliandro | Rosanna-F Cogliandro | Carla Caputo | Roberto De Giorgio | Giovanni Barbara | Vincenzo Stanghellini | A. Antonucci | L. Fronzoni | C. Caputo | Alexandra Antonucci
[1] C. Di Lorenzo,et al. Colonic manometry in children with chronic intestinal pseudo-obstruction. , 1993, Gut.
[2] H. Dudley,et al. Intestinal pseudo-obstruction. , 1958, Journal of the Royal College of Surgeons of Edinburgh.
[3] Warren Starkebaum,et al. Gastric electrical stimulation for medically refractory gastroparesis. , 2003, Gastroenterology.
[4] F. Ponti,et al. The pharmacological treatment of acute colonic pseudo‐obstruction , 2001 .
[5] M. Camilleri,et al. Human enteric neuropathies: morphology and molecular pathology , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[6] L. Zeltzer,et al. Discriminating Pediatric Condition Falsification from Chronic Intestinal Pseudo-Obstruction in Toddlers , 2002, Child maltreatment.
[7] P. Milla,et al. Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood , 1997 .
[8] E. Steiger,et al. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. , 1991, JPEN. Journal of parenteral and enteral nutrition.
[9] P. Hyman,et al. Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms , 1994, Digestive Diseases and Sciences.
[10] M. D. Schuffler,et al. Chronic idiopathic intestinal pseudo-obstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology. , 1982, Gastroenterology.
[11] P. Landais,et al. Home parenteral nutrition in adults: a multicentre survey in Europe. , 1989, Clinical nutrition.
[12] A. Kishida,et al. The application of radio-opaque markers prior to ileostomy in an infant with chronic intestinal pseudo-obstruction: Report of a case , 2006, Surgery Today.
[13] S. Cucchiara. Chronic Intestinal Pseudo‐Obstruction: The Clinical Perspective , 2001, Journal of pediatric gastroenterology and nutrition.
[14] T. O'hanrahan,et al. Spectrum of intestinal failure in a specialised unit , 1991, The Lancet.
[15] K. Hall,et al. Neural injury, repair and adaptation in the GI tract. I. New insights into neuronal injury: a cautionary tale. , 1998, The American journal of physiology.
[16] H. Mousa,et al. Quality of Life Outcomes in Congenital Chronic Intestinal Pseudo-Obstruction , 2002, Digestive Diseases and Sciences.
[17] J. Losanoff,et al. Eosinophilic enterocolitis and visceral neuropathy with chronic intestinal pseudo-obstruction. , 1999, Journal of clinical gastroenterology.
[18] C. Di Lorenzo,et al. Chronic intestinal pseudo-obstruction: assessment and management. , 2006, Gastroenterology.
[19] Thomas D. Bird,et al. A familial neuronal disease presenting as intestinal pseudoobstruction , 1978 .
[20] V. Ionasescu,et al. Inherited ophthalmoplegia with intestinal pseudo-obstruction , 1983, Journal of the Neurological Sciences.
[21] M. Camilleri,et al. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. , 1999, Gastroenterology.
[22] M. T. Ricci,et al. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. , 1984, AJR. American journal of roentgenology.
[23] A. Ballabio,et al. The locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28. , 1996, American journal of human genetics.
[24] M. Camilleri,et al. Small bowel manometry [1] (multiple letters) , 1997 .
[25] M. D. Schuffler,et al. Studies of idiopathic intestinal pseudoobstruction. I. Hereditary hollow visceral myopathy: clinical and pathological studies. , 1977, Gastroenterology.
[26] Kenton M Sanders,et al. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[27] M. Hirano,et al. ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy. , 2003, Human molecular genetics.
[28] A. L. Brown,et al. Chronic idiopathic intestinal pseudo-obstruction. , 1970, The American journal of medicine.
[29] M. D. Schuffler. Chronic intestinal pseudo-obstruction: progress and problems. , 1990, Journal of pediatric gastroenterology and nutrition.
[30] T. O'hanrahan,et al. The role of home parenteral nutrition in the management of intestinal failure - report of 400 cases. , 1992, Clinical nutrition.
[31] C. Rohrmann,et al. Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature. , 1981, Medicine.
[32] J. Baudon,et al. Chronic Intestinal Pseudoobstruction Syndrome Clinical Analysis, Outcome, and Prognosis in 105 Children , 1999, Digestive Diseases and Sciences.
[33] G. Lindberg,et al. Outcome of Colectomy for Slow-Transit Constipation in Relation to Presence of Small-Bowel Dysmotility , 2004, Diseases of the colon and rectum.
[34] F. Ponti,et al. Reduced Bcl-2 expression in the enteric nervous system (ENS) as a marker for neural degeneration in patients with gastrointestinal motor disorders (GIMD) , 2000 .
[35] H. Pitt,et al. Chronic intestinal pseudo-obstruction. Management with total parenteral nutrition and a venting enterostomy. , 1985, Archives of surgery.
[36] M. Fujishima,et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. , 1993, Gut.
[37] R. Sokol,et al. Gastrointestinal manifestations of mitochondrial disease. , 2003, Gastroenterology clinics of North America.
[38] I. Nishino,et al. Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase* , 2002, The Journal of Biological Chemistry.
[39] C. Di Lorenzo,et al. Intestinal transplantation in children with chronic intestinal pseudo-obstruction , 1999 .
[40] S. McDiarmid,et al. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. , 1988, The Journal of pediatrics.
[41] Gianrico Farrugia,et al. Chronic intestinal pseudoobstruction associated with altered interstitial cells of cajal networks. , 2003, Journal of pediatric gastroenterology and nutrition.
[42] M. Hirano,et al. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. , 2003, Biochemical and biophysical research communications.
[43] J. Fell,et al. Infantile chronic idiopathic intestinal pseudo-obstruction: the role of small intestinal manometry as a diagnostic tool and prognostic indicator. , 1996, Gut.
[44] D. Silk. Pseudo-pseudo-obstruction: lessons in diagnosis and management , 2004, European journal of gastroenterology & hepatology.
[45] D. Jain,et al. Role of Interstitial Cells of Cajal in Motility Disorders of the Bowel , 2003, American Journal of Gastroenterology.
[46] C. Di Lorenzo,et al. Long-Term Outcome of Congenital Intestinal Pseudoobstruction , 2002, Digestive Diseases and Sciences.
[47] P. Andrews,et al. Fundamentals of neurogastroenterology , 1999, Gut.
[48] S. Nixon,et al. Laparoscopic technique for small bowel biopsy , 1995, The British journal of surgery.
[49] G. Bassotti. Colonic manometry: for children only? A typical case of paradoxical motility. , 2003 .
[50] J. Mathias,et al. Neuromuscular diseases of the gastrointestinal tract. , 1995, Postgraduate medicine.
[51] A. Vincent,et al. Autoantibodies in patients with gut motility disorders and enteric neuropathy , 2007, Scandinavian journal of gastroenterology.
[52] M. Camilleri,et al. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. , 1995, The American journal of gastroenterology.
[53] C. Sninsky,et al. Chronic intestinal pseudo-obstruction. , 1995, Digestive Diseases.
[54] W. Jawaid,et al. Outcomes of pyloroplasty and pyloric dilatation in children diagnosed with nonobstructive delayed gastric emptying. , 2006, Journal of pediatric surgery.
[55] C. Streutker,et al. Loss of CD117 (c-kit)- and CD34-Positive ICC and Associated CD34-Positive Fibroblasts Defines a Subpopulation of Chronic Intestinal Pseudo-obstruction , 2003, The American journal of surgical pathology.
[56] G. Boeckxstaens,et al. Abnormal distribution of the interstitial cells of Cajal in an adult patient with pseudo-obstruction and megaduodenum , 2002, American Journal of Gastroenterology.
[57] R. Cuomo,et al. Reduced Bcl-2 expression and increased myenteric neuron apoptosis in patients with idiopathic enteric neuropathy (IEN) , 2005 .
[58] F. Ponti,et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases , 2002, American Journal of Gastroenterology.
[59] H. Parkman,et al. Chronic intestinal pseudo-obstruction , 2005, Current treatment options in gastroenterology.
[60] L. Barbara,et al. 12 Pseudo-obstruction syndromes , 1988, Baillière's Clinical Gastroenterology.
[61] C. Di Lorenzo,et al. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. , 1993, The American journal of gastroenterology.
[62] M. Rivkin,et al. Mitochondrial neurogastrointestinal encephalomyopathy: diagnosis by rectal biopsy. , 1998, The American journal of surgical pathology.
[63] D. Johns. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. , 1995, The New England journal of medicine.
[64] I. Sutton,et al. The immunopathogenesis of paraneoplastic neurological syndromes. , 2002, Clinical science.
[65] A. Zinsmeister,et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. , 1989, Gastroenterology.
[66] E. Vasiliauskas,et al. Chronic Intestinal Pseudoobstruction Associated with Fetal Alcohol Syndrome , 1997, Digestive Diseases and Sciences.
[67] G. Barbara,et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[68] S. Morinaga,et al. Cytochrome C oxidase deficiency in two siblings with leigh encephalomyelopathy , 1984, Brain and Development.
[69] A. Morelli,et al. Upper Gastrointestinal Motor Abnormalities in Children with Active Celiac Disease , 1995, Journal of pediatric gastroenterology and nutrition.
[70] Thymidine Phosphorylase Deficiency Causes MNGIE: An Autosomal Recessive Mitochondrial Disorder , 2004, Nucleosides, nucleotides & nucleic acids.
[71] P. Pasricha,et al. Neural stem cell transplantation in the enteric nervous system: roadmaps and roadblocks , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[72] I. Nishino,et al. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.
[73] S. Fullerton,et al. Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia , 1998, American Journal of Gastroenterology.
[74] A. Darzi,et al. Deranged smooth muscle α-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series , 2004, Gut.
[75] V. Carelli,et al. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 2007, FEBS letters.
[76] A. Morelli,et al. Pseudo-pseudo-obstruction. , 2004, European Journal of Gastroenterology and Hepathology.
[77] J. Rotter,et al. Familial visceral neuropathy with autosomal dominant transmission. , 1986, Gastroenterology.
[78] M. Norman,et al. Multiple system atrophy with neuronal intranuclear hyaline inclusions Report of a case and review of the literature , 1985, Journal of the Neurological Sciences.
[79] J. Keller,et al. Die chronische intestinale Pseudoobstruktion: Pathogenese, Diagnostik und Therapie , 2002 .
[80] C. Pope,et al. Studies of idiopathic intestinal pseudoobstruction. II. Hereditary hollow visceral myopathy: family studies. , 1977, Gastroenterology.
[81] C. Lorenzo. Pseudo-obstruction: current approaches. , 1999 .
[82] M. Salvatore,et al. Upper gastrointestinal tract motility in children with progressive muscular dystrophy. , 1992, The Journal of pediatrics.
[83] J. Cunningham,et al. Autoimmune pathogenesis of paraneoplastic neurological syndromes. , 1987, Critical reviews in neurobiology.
[84] A. Rühl. Glial cells in the gut , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[85] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[86] V. Smith,et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. , 1997, Gastroenterology.
[87] M. Kamm. Intestinal pseudo-obstruction , 2000, Gut.
[88] D. Jeffries,et al. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. , 1997, Gut.
[89] I. Gilron. Is gabapentin a "Broad-spectrum" analgesic? , 2002, Anesthesiology.
[90] A. Ciccodicola,et al. Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement. , 2007, American journal of human genetics.
[91] E. Pagnotta,et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. , 2003, Gastroenterology.
[92] G. Brandi,et al. Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease , 2005, The American Journal of Gastroenterology.
[93] V. Smith,et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction , 2003, Gut.
[94] S. Dimauro,et al. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations , 2000, Annals of neurology.
[95] D. Schofield,et al. What is intestinal neuronal dysplasia? , 1991, Pathology annual.
[96] M. Sood,et al. Visceral Pain-Associated Disability Syndrome: A Descriptive Analysis , 2002, Journal of pediatric gastroenterology and nutrition.
[97] P. Puri. Chronic idiopathic intestinal pseudo-obstruction: Clinical and intestinal manometric findings , 1987 .
[98] I. Mena,et al. Cisapride in children with chronic intestinal pseudoobstruction: An acute, double-blind, crossover, placebo-controlled trial , 1991 .
[99] W. Hasler,et al. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. , 1991, The New England journal of medicine.
[100] B. Flourié,et al. Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE). , 2005, Gastroenterologie clinique et biologique.
[101] S. Dimauro,et al. A Novel Mitochondrial G8313A Mutation Associated with Prominent Initial Gastrointestinal Symptoms and Progressive Encephaloneuropathy , 1997, Pediatric Research.
[102] J. Huizinga,et al. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders. , 1997, Trends in pharmacological sciences.
[103] M. Masetti,et al. Intestinal Transplantation for Chronic Intestinal Pseudo‐Obstruction in Adult Patients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[104] D. Redden,et al. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease. , 1999, Journal of autoimmunity.
[105] A. Uc,et al. Analysis of fasting antroduodenal manometry in children , 1996, Digestive Diseases and Sciences.
[106] L. Gillis,et al. Diagnosis and management of mitochondrial diseases. , 2002, Pediatric clinics of North America.
[107] J. Reyes,et al. 2003 Report of the Intestine Transplant Registry: A New Era Has Dawned , 2005, Annals of surgery.
[108] Assessment of gastric emptying using a low fat meal: Establishment of international control values , 2000 .
[109] R. Patel,et al. Chronic intestinal pseudo-obstruction: diagnosis and treatment. , 1995, Der Gastroenterologe.
[110] P. Sachs,et al. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. , 1988, Journal of pediatric gastroenterology and nutrition.
[111] M. Camilleri,et al. Symptomatic improvement with one‐year cisapride treatment in neuropathic chronic intestinal dysmotility. , 1996, Alimentary pharmacology & therapeutics.
[112] R. De Giorgio,et al. Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. , 1992, Hepato-gastroenterology.
[113] A. Perez-Atayde,et al. Diagnosis and management of MNGIE syndrome in children: case report and review of the literature. , 2002, Journal of pediatric gastroenterology and nutrition.
[114] C. Di Lorenzo,et al. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. , 1995, Gastroenterology.
[115] M. Masetti,et al. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. , 2004, Transplantation proceedings.
[116] L. Techner,et al. Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Major Abdominal Surgery and Postoperative Ileus , 2004, Annals of surgery.
[117] R. Summers,et al. Acute intestinal obstruction: an electromyographic study in dogs. , 1983, Gastroenterology.
[118] Hyun-Young Kim,et al. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children. , 2005, Journal of pediatric surgery.
[119] C. Sninsky,et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction , 1995, Digestive Diseases and Sciences.
[120] T. Parsons,et al. Mitochondrial enteropathy: the primary pathology may not be within the gastrointestinal tract , 2001, Gut.
[121] V. Annese,et al. Antroduodenojejunal Manometry in the Diagnosis of Chronic Idiopathic Intestinal Pseudoobstruction in Children , 1994, Journal of pediatric gastroenterology and nutrition.
[122] G. Barbara,et al. New insights into human enteric neuropathies , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[123] J. Malagelada,et al. Manometric evaluation of functional upper gut symptoms. , 1985, Gastroenterology.
[124] N. Nevin,et al. Idiopathic intestinal pseudo‐obstruction: A familial visceral neuropathy , 1980, Clinical genetics.
[125] Y. Anikster,et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE , 2006, Neurology.
[126] J. M. Villares. Pseudo-obstrucción intestinal crónica primaria debida a miopatía visceral , 2006 .
[127] A. Francavilla,et al. Total parenteral nutrition-related gastroenterological complications. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[128] I. Nishino,et al. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. , 2004, Clinical chemistry.
[129] H. Pitt,et al. Increased risk of gallstones in children receiving total parenteral nutrition. , 1983, Pediatrics.
[130] M. Devoto,et al. A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23–q24 , 2007, European Journal of Human Genetics.
[131] Y. Aigrain,et al. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus. , 1984, The New England journal of medicine.
[132] J. Ellul,et al. Percutaneous endoscopic colostomy in patients with chronic intestinal pseudo-obstruction. , 2004, Gastrointestinal endoscopy.
[133] W. Meier-Ruge,et al. An evaluation of the role of suction rectal biopsy in the diagnosis of intestinal neuronal dysplasia. , 1997, Journal of pediatric gastroenterology and nutrition.
[134] A. Zinsmeister,et al. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. , 1994, Gastroenterology.
[135] V. Lennon,et al. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. , 2006, Gastroenterology.
[136] L. Spitz,et al. Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients , 1999, Archives of disease in childhood.
[137] H. Rosner,et al. Gabapentin adjunctive therapy in neuropathic pain states. , 1996, The Clinical journal of pain.
[138] C. Faure,et al. Manometrical Evaluation in Visceral Neuropathies in Children , 1994, Journal of pediatric gastroenterology and nutrition.
[139] J. Gidda,et al. Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. , 1994, Journal of medicinal chemistry.
[140] S. Todo,et al. "Munchausen by proxy" syndrome in a small bowel transplant recipient. , 1996, Transplantation proceedings.
[141] M. Kamm,et al. Erythromycin for the treatment of chronic intestinal pseudo‐obstruction: description of six cases with a positive response , 2004, Alimentary pharmacology & therapeutics.
[142] B. Dahms,et al. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. , 1981, Gastroenterology.
[143] J. Palo,et al. Neuronal intranuclear inclusion disease in identical twins , 1984, Annals of neurology.
[144] C. Di Lorenzo,et al. Intestinal motility in symptomatic children with fundoplication. , 1991, Journal of pediatric gastroenterology and nutrition.
[145] H. Lönroth,et al. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[146] L. Salberg,et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 1994, Neurology.
[147] J. Finsterer. Mitochondriopathies , 2004, European journal of neurology.
[148] A. Zinsmeister,et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility , 1991, Digestive Diseases and Sciences.
[149] I. Sasaki,et al. Surgical Treatment of Chronic Intestinal Pseudo-Obstruction: Report of Three Cases , 2003, Surgery Today.
[150] T. M. Kidder,et al. Manometric characteristics of cervical dysphagia in a patient with the Kearns-Sayre syndrome. , 1992, Gastroenterology.
[151] A. Amiot,et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. , 2009, Gastroenterology.
[152] G. D. Gardner,et al. A familial visceral myopathy. , 1978, Annals of internal medicine.
[153] M. Camilleri. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. , 1989, Gut.
[154] B. Nyberg,et al. Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases , 2009, Histopathology.
[155] C. Granata,et al. Megacystis-microcolon-intestinal hypoperistalsis syndrome. , 1997, Journal of pediatric gastroenterology and nutrition.
[156] G. Barbara,et al. Chronic intestinal pseudo‐obstruction: manifestations, natural history and management , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[157] S. Dimauro,et al. MELAS: An original case and clinical criteria for diagnosis , 1992, Neuromuscular Disorders.
[158] V. Ionasescu,et al. A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission. , 1983, Gastroenterology.
[159] G. Lyford,et al. Chronic intestinal pseudoobstruction , 2004, Current treatment options in gastroenterology.
[160] K Isozaki,et al. Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. , 1997, The American journal of gastroenterology.
[161] Xia Yang,et al. A Systematic Review on Intrapyloric Botulinum Toxin Injection for Gastroparesis , 2009, Digestion.
[162] G. Barbara,et al. Inflammatory neuropathies of the enteric nervous system. , 2004, Gastroenterology.
[163] M. Ducreux,et al. Simultaneous decompression colonoscopy and radiologic G-tube insertion in a patient with megacolon because of chronic colonic pseudo-obstruction. , 2005, Gastrointestinal endoscopy.
[164] M. D. Schuffler,et al. Pathology of neuromuscular disorders of the small intestine and colon. , 1987, Gastroenterology.
[165] C. Lorenzo,et al. Colonic manometry in children with defecatory disorders: Role in diagnosis and management , 2003, American Journal of Gastroenterology.
[166] I. Nicoletti,et al. Intestinal Pseudoobstruction Secondary to Hypothyroidism. Importance of Small Bowell Manometry , 1992, Journal of clinical gastroenterology.
[167] M. Joseph,et al. A curable cause of chronic idiopathic intestinal pseudo-obstruction in children: idiopathic myositis of the small intestine. , 1996, Journal of pediatric gastroenterology and nutrition.
[168] P. Hyman,et al. Tolerance to intravenous ranitidine. , 1987, The Journal of pediatrics.
[169] R. De Giorgio,et al. Unusual complication of tuberous sclerosis complex , 2004, Gut.
[170] M. Kamm,et al. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults , 1997, Gut.